See on Scoop.it – Health and Inhumanity
“It’s time for the CDC and the NIH to abandon the failed two-tiered strategy and stop funding tests like the C6, which do no better. Patients want diagnostic tests with greater sensitivity so that patients can get diagnosed and treated. A recent article pegs the number of Lyme tests performed annually at 3.4 million—which translates into a market of roughly $340 million a year. Not only do these numbers suggest that there is a lot more Lyme around than the CDC or IDSA acknowledge, but they also tell us that commercially vested interests and the researchers they consult with may have a stake in keeping the status quo in lab testing regardless of how bad the tests are.Could monetary considerations have something to do with opposition to new lab tests?”